Comparative Effectiveness and Toxicity of Cetuximab or Cisplatin With Concurrent Radiation for Locoregionally Advanced Squamous Cell Carcinoma of The Head And Neck: A Population-Based Analysis

被引：0
|
作者：
Xiang, Michael [1 ]
Holsinger, Floyd Christopher [1 ]
Chen, Michelle [1 ]
Colevas, Alexander Dimitrios [1 ]
Beadle, Beth Michelle [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 101卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA36
引用
收藏
页码：E16 / E16
页数：1
相关论文
共 50 条
  • [1] Comparative Effectiveness of Cetuximab or Cisplatin With Concomitant Radiation for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck: A Population-Based Analysis
    Xiang, M.
    Holsinger, F. C.
    Chen, M. M.
    Colevas, A. D.
    Beadle, B. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1322 - 1322
  • [2] Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro
    Zhang, Na
    Erjala, Kaisa
    Kulmala, Jarmo
    Qiu, Xueshan
    Sundvall, Maria
    Elenius, Klaus
    Grenman, Reidar
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 92 (03) : 388 - 392
  • [3] Cisplatin or Carboplatin-Based Chemoradiation for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck: A Population-Based Comparison
    Xiang, M.
    Holsinger, F. C.
    Colevas, A. D.
    Hara, W.
    Le, Q. T.
    Beadle, B. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E371 - E371
  • [4] Outcomes of concurrent radiation with cisplatin versus cetuximab in locally-advanced head and neck squamous cell carcinoma (LAHNSCC).
    Ly Viet Do
    Dowlatshahi, Morteza
    Parekh, Zayd
    Trevino, Richard
    Eng, Richard
    Fann, Karen
    Dinh, Ngon
    Lee, Raymond W.
    Lee, Charlene Sen-Yee
    Hla, Tin T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Phase I Trial of Bevacizumab followed by Concurrent Radiation, Bevacizumab and Cisplatin for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
    Harari, P. M.
    Khuntia, D.
    Traynor, A. M.
    Hoang, T.
    Hartig, G. K.
    McCulloch, T. M.
    Jeraj, R.
    Nyflot, M.
    Wiederholt, P. A.
    Gentry, L. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S104 - S104
  • [6] Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States
    Himani Aggarwal
    Rajeshwari S. Punekar
    Li Li
    Gebra Cuyun Carter
    Mark S. Walker
    [J]. Health and Quality of Life Outcomes, 18
  • [7] Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States
    Aggarwal, Himani
    Punekar, Rajeshwari S.
    Li, Li
    Carter, Gebra Cuyun
    Walker, Mark S.
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
  • [8] Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck
    Riaz, Nadeem
    Sherman, Eric
    Koutcher, Lawrence
    Shapiro, Lauren
    Katabi, Nora
    Zhang, Zhigang
    Shi, Weiji
    Fury, Mathew
    Wong, Richard
    Wolden, Suzanne
    Rao, Shyam
    Lee, Nancy
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 27 - 31
  • [9] Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma A meta-analysis
    Tang, Wen-Hua
    Sun, Wei
    Long, Guo-Xian
    [J]. MEDICINE, 2020, 99 (36)
  • [10] Concurrent radiotherapy with carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma
    Saigal, Kunal
    Santos, Edgardo S.
    Tolbe, Khaled
    Kwon, Deukwoo
    Elsayyad, Nagy
    Abramowitz, Matthew C.
    Mandalia, Amar
    Samuels, Michael Andrew
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
12345